Diagnostic pitfall: BCOR immunoreactivity in a molecularly confirmed astroblastoma, MN1-altered (HGNET-MN1)
Clinical Neuropathology · 01.01.2026 · 45 (01) · 32-35
DOI: 10.5414/np301715 ↗Kurz gefasst
Fachartikel in der Zeitschrift Clinical Neuropathology, erschienen am 01.01.2026. Verfasst von Palgun Nisarga und 7 weiteren Autor:innen.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Zitieren
APA
Nisarga, P., Rathore, B., Hodjat, P., Derinkuyu, B. E., Graham, R. T., Skoch, J., Leino, D., & Gupta, K. (2026). Diagnostic pitfall: BCOR immunoreactivity in a molecularly confirmed astroblastoma, MN1-altered (HGNET-MN1). Clinical Neuropathology, 45(01), 32-35. https://doi.org/10.5414/np301715
Vancouver
Nisarga P, Rathore B, Hodjat P, Derinkuyu BE, Graham RT, Skoch J, et al. Diagnostic pitfall: BCOR immunoreactivity in a molecularly confirmed astroblastoma, MN1-altered (HGNET-MN1). Clinical Neuropathology. 2026;45(01):32-35. doi:10.5414/np301715
BibTeX
@article{Nisarga2026,
author = {Nisarga, Palgun and Rathore, Bhagyashree and Hodjat, Parsa and Derinkuyu, Betul E and Graham, Richard T and Skoch, Jesse and Leino, Daniel and Gupta, Kirti},
title = {Diagnostic pitfall: BCOR immunoreactivity in a molecularly confirmed astroblastoma, MN1-altered (HGNET-MN1)},
journal = {Clinical Neuropathology},
year = {2026},
volume = {45},
number = {01},
pages = {32--35},
doi = {10.5414/np301715}
}
EUVIMED